Synergistic and Additive Effects of Cimetidine and Levamisole on Cellular Immune Responses to Hepatitis B virus DNA Vaccine in Mice

Scandinavian Journal of Immunology

Volumn 77, Issue 2, 2013, Pages 84-91

  Niu, X ^a   Yang, Y ^a   Wang, J ^a,b  

^a HENAN UNIVERSITY   (China)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD86 ANTIGEN; CIMETIDINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LEVAMISOLE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DNA IMMUNIZATION; DRUG POTENCY; DRUG POTENTIATION; FEMALE; HELPER CELL; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; CIMETIDINE; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DRUG SYNERGISM; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; LEVAMISOLE; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; VACCINES, DNA;

EID: 84872842423     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12018     Document Type: Article

References (33)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
2. Lok ASF. Chronic hepatitis B. N Engl J Med 2002;346:1682-3.
3. Malik AH, Lee WM. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med 2000;132:723-31.
4. D'Souza R, Foster GR. Diagnosis and treatment of chronic hepatitis B. J R Soc Med 2004;97:318-21.
5. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000;192:921-30.
6. Dunn C, Brunetto M, Reynolds G et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007;204:667-80.
7. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol 2006;87:1439-49.
8. Nam SH, Park JH, Kang JH et al. Modulation of immune response induced by co-administration of DNA vaccine encoding HBV surface antigen and HCV envelope antigen in BALB/c mice. Arch Pharm Res 2006;29:1042-8.
9. zu Putlitz J, Encke J, Wands JR. Cytotoxic T cell responses against hepatitis B virus polymerase induced by genetic immunization. J Hepatol 2000;33:986-91.
10. Geissler M, Schirmbeck R, Reimann J, Blum HE, Wands JR. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice. Hepatology 1998;28:202-10.
11. Davis HL, McCluskie MJ, Gerin JL, Purcell RH. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. PNAS 1996;93:7213-8.
12. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel M-L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. PNAS 1996;93:12496-501.
13. Davis HL, Brazolot Millan CL, Mancini M et al. DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice. Vaccine 1997;15:849-52.
14. Davis HL, Brazolot Millan CL. DNA-based immunization against hepatitis B virus. Springer Semin Immunopathol 1997;19:195-209.
15. Jin H, Li Y, Ma Z et al. Effect of chemical adjuvants on DNA vaccination. Vaccine 2004;22:2925-35.
16. Wang J, Su B, Ding Z, Du X, Wang B. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells. Biochem Biophys Res Commun 2008;372:491-6.
17. Sahasrabudhe DM, McCune CS, O'Donnell RW, Henshaw EC. Inhibition of suppressor T lymphocytes (Ts) by cimetidine. J Immunol 1987;138:2760-3.
18. Ershler WB, Hacker MP, Burroughs BJ, Moore L, Myers CF. Cimetidine and the immune response: I. In vivo augmentation of nonspecific and specific immune response. Clin Immunol Immunopathol 1983;26:10-7.
19. Zhang W, Du X, Zhao G et al. Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination. Vaccine 2009;27:4938-46.
20. Chen LY, Lin YL, Chiang BL. Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells. Clin Exp Immunol 2008;151:174-81.
21. Wang J, Song H, Tang X et al. Effect of exercise training intensity on murine T-regulatory cells and vaccination response. Scand J Med Sci Sports 2012;22:643-52.
22. Du X, Zheng G, Jin H et al. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J Gene Med 2007;9:136-46.
23. Zhang W, Wang J, Su B et al. Cimetidine augments Th1/Th2 dual polarized immune responses to recombinant HBV antigens. Vaccine 2011;29:4862-8.
24. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol 2009;21:1105-11.
25. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-29.
26. Webster GJ, Reignat S, Maini MK et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000;32:1117-24.
27. Zheng BJ, Zhou J, Qu D et al. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat 2004;11:217-24.
28. McCarty MF. Cimetidine as an adjuvant for allogeneic lymphocyte immunotherapy of cancer. Med Hypotheses 1985;17:155-6.
29. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994;35:1632-6.
30. Toka FN, Suvas S, Rouse BT. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J Virol 2004;78:13082-9.
31. Sutmuller RPM, van Duivenvoorde LM, van Elsas A et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-32.
32. Furuichi Y, Tokuyama H, Ueha S, Kurachi M, Moriyasu F, Kakimi K. Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization. World J Gastroenterol 2005;11:3772-7.
33. Frimpong-Boateng K, van Rooijen N, Geiben-Lynn R. Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta. PLoS ONE 2010;5:e12281.